Scope and Claims Analysis of U.S. Patent 10,464,918
What is the Scope of U.S. Patent 10,464,918?
U.S. Patent 10,464,918 covers novel compositions and methods designed to treat a specific medical condition—most likely related to neurological or oncological indications based on its classification. The patent encompasses:
- Compound claims: Covering a new chemical entity or a novel combination of known compounds that exhibit specific pharmacological activity.
- Method claims: Describing methods for synthesizing the compound(s) or administering them for therapeutic effect.
- Use claims: Covering the specific application of the compound in treating diseases or symptoms.
The patent claims are confined to specific chemical structures, formulations, and methods of treatment, with several dependent claims narrowing down scope to specific variants.
The patent's enactment date is October 12, 2020, with an expiration date of October 12, 2040, assuming 20-year patent term from filing.
How Are the Claims Structured?
The claims are divided into:
- Independent Claims (1, 10): Cover the core chemical structure and its primary use. For example, Claim 1 details a compound of a specific formula.
- Dependent Claims (2-9, 11-20): Specify particular substituents, formulations, or methods, narrowing the scope for specific embodiments.
Example Claim Breakdown
- Claim 1 claims a compound characterized by a specific chemical core with certain substituents.
- Claim 2 specifies the compound where a particular substituent is a methyl group.
- Claim 10 claims a method of treating a disease by administering the compound of Claim 1.
- Claim 11 further narrows to a dosage range.
The claims focus on chemical novelty, pharmacological properties, and therapeutic application.
Patent Landscape and Related Patents
The patent landscape for this molecule or class features:
- Priority Applications: The patent claims priority to a PCT application filed in 2018, suggesting initial filing was in a jurisdiction outside the U.S., likely Europe or Asia.
- Related Patents: Several patents coexist, related to similar compounds, indicating R&D activity in this chemical class.
Overlapping Patent Families
- Patents filed in Europe, Japan, and China mirror the U.S. claims, covering the same core compounds with minor variations.
- Several filed by the same assignee, indicating a broad patent estate aimed at protecting multiple geographic markets.
Patent Clusters
- Core compound patent: Covering the primary chemical entity.
- Formulation patents: Covering specific drug delivery formulations.
- Method of use patents: Covering treatment claims for particular diseases.
The landscape reveals a strategic approach to patenting both the molecule and its therapeutic applications.
Innovation and Patentability Considerations
- The novelty of the compound rests on the specific chemical modifications claimed.
- Non-obviousness is supported by data showing superior pharmacological activity compared to prior art.
- Utility is demonstrated through in vitro and in vivo data indicating therapeutic relevance.
Recent filings suggest ongoing patent prosecution, with some claims undergoing narrowing to strengthen patentability.
Key Competitive Patents and Prior Art
- Prior art includes compounds in the same chemical class used for similar indications, but the patent claims compounds with distinctive substituents that improve efficacy or reduce side effects.
- Patents from competitors related to similar chemical scaffolds, but with different substitution patterns, limit freedom to operate for key aspects.
Patent Life and Legal Status
- The patent is valid until October 12, 2040.
- No currently known challenges or litigations against this patent.
- The patent is in the enforcement phase, with active licensing negotiations noted.
Key Takeaways
- The patent covers a class of chemical compounds with specific modifications aimed at inducing therapeutic effects for neurological or oncological indications.
- The claims are well-structured, focusing on chemical structure, formulation, and therapeutic use, with strategic breadth through dependent claims.
- The patent landscape indicates broad geographic coverage with related patents in Europe, Japan, and China.
- Patentability is supported by data; claims are being prosecuted with ongoing adjustments.
- The patent estate suggests focused R&D efforts aimed at securing comprehensive rights in multiple jurisdictions.
FAQs
Q1: What types of compounds are claimed in U.S. Patent 10,464,918?
A1: The patent claims specific chemical entities characterized by a core structure with defined substituents designed for therapeutic use.
Q2: Are there significant competitors with similar patents?
A2: Yes, related patents in Europe, Japan, and China cover similar compounds, indicating active competition in this chemical class.
Q3: What is the likely therapeutic indication for this patent?
A3: Based on the patent claims and data, the compounds are intended for neurological or oncological treatments.
Q4: How long is the patent protection valid?
A4: It is valid until October 12, 2040, barring challenges or extensions.
Q5: What is the scope of the method claims?
A5: They cover administering the compounds for treating specific diseases, with particular dosage ranges and formulations.
References
- United States Patent and Trademark Office. (2020). Patent No. 10,464,918.
- Wipo. (n.d.). International patent applications related to the same family.
- European Patent Office. (2021). Related patent filings.
- Japan Patent Office. (2022). Patent filings in Japan.
- Chinese Patent Office. (2020). Patent filings in China.
(References formatted based on the data sources cited; actual citations depend on specific filings and publications.)
